Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48649
Título: Primary T lymphocyte immunodeficiency associated with a selective impairment of CD2, CD3, CD43 (but not CD28)-mediated signal transduction
Autores/as: Rodriguez-Gallego, C. 
Arnaiz-Villena, A.
Corell, A.
Manzanares, J.
Timon, M.
Pacheco, A.
Regueiro, J. R.
Clasificación UNESCO: 32 Ciencias médicas
3205 Medicina interna
Palabras clave: CD28 Antigens
Cytokines
Immunologic Deficiency Syndromes
Fecha de publicación: 1994
Publicación seriada: Clinical and experimental immunology (Print) 
Resumen: A 2-year-old female with important signs of immune response failure against virus, bacteria, fungi and protozoa and no obvious humoral or lymphocyte phenotypical defect was studied. Both peripheral blood mononuclear cells and IL-2-dependent T cell lines derived from the patient showed a severe selective T cell activation impairment via CD2, CD3 and CD43; however, this defect was reversible with the addition of either IL-2, or phorbol myristate acetate (PMA) or anti-CD28 antibodies. Concordantly, the induction of IL-2 (and, in part, IL-3 and IL-4) messenger RNA was severely reduced in stimulated T cells, but that of other cytokines was either normal (IL-5) or only slightly diminished (interferon-gamma (IFN-gamma)). It is concluded that an activation T cell defect exists previous to protein kinase C (PKC) and between membrane receptors and the activation pathway of certain response genes encoding for interleukins involved in proliferation (i.e. IL-2, IL-3 and IL-4), but not of others (i.e. IL-5). The use of T cell lines from human T lymphocyte activation deficiencies allows dissection of T cell pathology and the corresponding physiological pathways. In the present description, there is an evident independence of the CD28 T cell activation pathway from those induced through CD2 or CD3, and the differential gene regulation of the different interleukins.
URI: http://hdl.handle.net/10553/48649
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.1994.tb06099.x
Fuente: Clinical and Experimental Immunology[ISSN 0009-9104],v. 97, p. 386-391 (Septiembre 1994)
Colección:Artículos
Vista completa

Citas SCOPUSTM   

5
actualizado el 24-mar-2024

Visitas

38
actualizado el 12-ago-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.